preced
chapter
describ
essenti
aspect
viral
pathogenesi
includ
viruscel
interact
viral
spread
within
host
intrins
innat
adapt
immun
respons
chapter
extend
theme
address
divers
pattern
viral
infect
determin
viru
host
thu
virul
suscept
depend
upon
specif
virushost
combin
particularli
true
case
persist
infect
involv
delic
balanc
viru
host
focu
first
viru
virul
host
suscept
turn
complex
variabl
govern
persist
infect
chapter
innat
adapt
aberr
immun
chapter
system
biolog
approach
also
provid
import
insight
pattern
infect
viral
virul
pathogen
abil
viru
caus
diseas
infect
host
sinc
variant
singl
viru
exhibit
differ
level
sever
viral
virul
import
consider
studi
pattern
diseas
furthermor
understand
subtleti
viral
virul
import
practic
implic
sinc
avirul
attenu
variant
viru
often
use
live
vaccin
exampl
smallpox
poliomyel
measl
yellow
fever
virul
phenotyp
depend
upon
mani
variabl
includ
viral
strain
rout
infect
viral
inoculum
speci
age
genet
suscept
host
profil
differ
virul
attenu
virus
may
necessari
choos
experiment
combin
host
rout
somewher
spectrum
benign
sever
end
diseas
scale
compar
pathogenesi
virul
avirul
viru
strain
use
elucid
biolog
mechan
underli
phenotyp
differ
virul
phenotyp
qualit
quantit
qualit
variat
may
manifest
variou
way
instanc
viral
clone
may
exhibit
differ
tropism
one
clone
replic
well
brain
anoth
clone
replic
well
liver
gastrointestin
tract
altern
differ
clone
may
spread
differ
rout
one
clone
produc
viremia
wherea
anoth
spread
neural
rout
instanc
viral
clone
vari
innat
acquir
immun
respons
induc
suscept
antibodi
cellular
immun
defens
quantit
given
express
pathogen
possibl
compar
number
infecti
unit
requir
produc
specifi
outcom
mortal
diseas
paramet
differ
viral
strain
eg
quantit
measur
virul
measur
variou
method
summar
tabl
death
binari
outcom
ideal
measur
experiment
model
differ
virul
pronounc
subtl
analysi
use
exampl
virul
avirul
strain
uniformli
fatal
yet
vari
averag
day
death
experiment
host
common
measur
virul
paralysi
eg
polioviru
chang
liver
enzym
hepat
viru
decreas
proport
number
lymphocyt
immunodefici
virus
sometim
distant
surrog
measur
behavior
abnorm
neurotrop
virus
comparison
virul
use
ratio
infecti
unit
diseas
outcom
instanc
viru
form
plaqu
vitro
calcul
make
possibl
distinguish
differ
degre
virul
modern
assay
rna
dna
copi
use
potenti
pitfal
seldom
measur
complet
copi
viral
genom
could
affect
incomplet
genom
incap
replic
assess
rel
virul
two
strain
given
viru
caus
similar
diseas
infecti
unit
per
diseas
endpoint
compar
second
row
tabl
clinic
set
virul
sometim
measur
differ
approach
requir
outbreak
possibl
estim
number
infect
occur
popul
well
number
clinic
case
instanc
ratio
case
per
infect
provid
measur
virul
qualit
measur
qualit
comparison
describ
differ
local
patholog
chang
natur
instanc
figur
show
comparison
central
nervou
system
cn
lesion
caus
five
neurotrop
flavivirus
virus
produc
sever
lesion
brain
other
target
spinal
cord
produc
similar
lesion
throughout
neuraxi
reflect
multidimension
natur
virul
virus
manipul
alter
virul
either
deliber
inadvert
classic
accomplish
grow
viru
either
anim
cell
cultur
tabl
advent
molecular
genet
becom
possibl
introduc
mutat
chang
virul
studi
inform
phenotyp
differ
much
possibl
one
simplest
method
obtain
viru
strain
differ
virul
select
genet
clone
viru
compar
use
one
measur
describ
prefer
done
pick
plaqu
cultur
plate
method
use
albert
sabin
identifi
attenu
strain
poliovirus
develop
pioneer
day
virolog
virus
often
maintain
serial
passag
anim
host
found
pathogen
would
chang
cours
multipl
passag
adventiti
find
exploit
obtain
virus
differ
pathogen
gener
repeat
animaltoanim
transmiss
viru
adapt
order
replic
optim
condit
passag
yellow
fever
flaviviru
produc
fatal
hepat
monkey
passag
intracerebr
mice
becom
highli
neurovirul
mice
lose
abil
caus
hepat
monkey
howev
natur
virus
adapt
specif
host
virul
may
vari
high
rabi
raccoon
fox
smallpox
human
low
sar
coronaviru
bat
rhinovirus
human
similarli
complex
experiment
passag
strain
simian
immunodefici
viru
siv
led
neurovirul
strain
less
capabl
caus
immunodefici
use
studi
neurovirul
coinocul
immunodefici
caus
viru
advent
cell
cultur
virus
usual
maintain
vitro
passag
soon
observ
serial
transmiss
alter
biolog
phenotyp
often
reduc
histor
failur
recogn
influenc
passag
upon
biolog
phenotyp
led
import
error
virolog
research
exampl
intracerebr
passag
polioviru
monkey
lead
select
variant
highli
neurotrop
lost
much
infect
pathogen
administ
oral
natur
rout
pathogenesi
studi
neuroadapt
polioviru
result
erron
conclus
polioviru
enteroviru
natur
transmit
intranas
rout
misapprehens
led
trial
nasal
astring
spray
method
protect
children
paralysi
recent
passag
cell
line
select
laboratori
variant
differ
wildtyp
viru
abil
plaqu
cell
cell
line
use
coreceptor
receptor
inabl
infect
macrophag
use
serolog
assay
adapt
virus
readili
neutral
sera
patient
natur
infect
hiv
find
result
mistaken
conclus
could
readili
neutral
consequ
predict
would
rel
easi
develop
prophylact
vaccin
recogn
viral
isol
maintain
natur
phenotyp
passag
primari
blood
mononuclear
cell
pbmc
becam
clear
mani
wild
type
hiv
isol
resist
neutral
present
daunt
challeng
vaccin
develop
number
method
use
enhanc
select
attenu
viru
variant
unclon
viru
stock
temperaturesensit
mutant
wild
type
virus
replic
well
often
temperatur
cell
cultur
thrive
temperatur
sensit
ts
variant
hand
replic
well
poorli
rel
easi
select
temperatur
sensit
variant
often
exhibit
attenu
phenotyp
test
anim
restrict
infect
rang
host
tissu
anoth
method
select
attenu
mutant
passag
low
temperatur
lowest
temperatur
mammalian
cell
cultur
maintain
coldadapt
influenza
viru
temperatur
sensit
exhibit
restrict
pneumotrop
ferret
anim
develop
sever
pneumonia
intranas
infect
wildtyp
human
influenza
virus
massaab
et
al
attenu
strain
use
live
influenza
vaccin
see
chapter
viral
vaccin
determin
viral
virul
may
encod
part
viral
genom
chang
nucleotid
dramat
effect
virul
last
decad
larg
bodi
inform
assembl
regard
determin
summar
sidebar
salient
exampl
describ
use
mutant
viral
clone
made
possibl
identifi
role
specif
gene
protein
determin
virul
l
master
gene
protein
determin
virul
attenu
may
associ
chang
viral
protein
well
untransl
genom
sequenc
l
virul
phenotyp
alter
dramat
chang
lead
alter
singl
amino
acid
singl
nucleotid
chang
noncod
region
variant
mutat
sever
critic
site
may
attenu
singl
point
mutat
frequenc
revers
virul
invers
proport
number
discret
attenu
mutat
l
revers
virul
attenu
variant
involv
back
mutat
genet
site
attenu
also
produc
compensatori
mutat
differ
site
protein
even
anoth
viral
protein
l
attenu
mutat
often
host
rang
alter
affect
replic
cell
tissu
other
l
although
mani
attenu
viral
variant
identifi
rel
instanc
mechan
identifi
biochem
structur
level
opv
compris
attenu
clone
three
polioviru
serotyp
thatin
comparison
virul
wildtyp
polioviruseshav
markedli
reduc
neurovirul
direct
intrathalam
intraspin
inject
macaqu
opv
virus
revert
virul
feed
humanssuch
strain
routin
isol
stool
vaccin
childrenhav
small
number
nucleotid
differ
comparison
attenu
parent
vaccin
strain
recombin
parent
revert
opv
virus
therefor
use
identifi
influenc
individu
critic
nucleotid
neuropathogenesi
minor
opv
four
import
nucleotid
determin
locat
nontransl
region
genom
gene
encod
structur
protein
case
influenza
viru
chang
virul
may
also
due
specif
combin
viral
gene
long
mysteri
influenza
epidem
caus
high
mortal
estim
million
death
analysi
use
recombin
virusesconstruct
gene
reassort
reconstruct
viru
lesspathogen
contemporari
strainind
virul
multigen
tabl
pathogenesi
analysi
show
viru
trigger
outpour
cell
cytokin
lung
reflect
profil
gene
express
instanc
host
respons
deleteri
determin
viru
virul
introduct
molecular
genet
virolog
becom
rel
easi
alter
viral
genom
control
manner
genet
chang
deliber
introduc
includ
point
mutat
alter
function
individu
protein
inactiv
nonessenti
viral
gene
introduct
stop
codon
delet
substanti
gene
segment
relev
method
describ
chapter
instanc
hiv
four
accessori
genesnef
vif
vpu
vprthat
essenti
replic
cell
cultur
siv
strain
lack
one
gene
attenu
use
infect
rhesu
macaqu
compar
parent
counterpart
fact
hope
hiv
strain
lack
nef
gene
might
use
attenu
viral
vaccin
human
group
patient
infect
natur
nefdelet
strain
hiv
remain
healthi
absent
antiretrovir
treatment
mani
year
eventu
develop
aid
end
approach
vaccin
nefdelet
hiv
strain
attenu
still
danger
use
human
anoth
pertin
exampl
strain
influenza
viru
produc
high
mortal
among
poultri
farmer
china
investig
potenti
transmiss
therefor
virul
human
popul
viru
two
research
group
independ
conduct
controversi
gainoffunct
experi
surrog
human
subject
investig
team
use
ferret
although
ferret
could
infect
intranas
wildtyp
viru
transmit
infect
ferret
hous
close
proxim
howev
research
introduc
mutat
perform
animaltoanim
passag
obtain
viru
mutant
transmiss
aerosol
recent
genet
analys
suggest
least
three
transmiss
determin
viru
basic
amino
acid
adjac
cleavag
site
viral
hemagglutinin
amino
acid
one
viral
polymeras
molecul
short
sequenc
protein
may
influenc
interferon
host
respons
sequenti
step
viral
pathogenesi
describ
chapter
basic
concept
abil
viru
move
step
impact
virul
exampl
virus
differ
infect
portal
entri
abil
dissemin
replic
capac
target
organ
tissu
mani
instanc
pathogen
viru
strain
determin
abil
evad
host
defens
intrins
innat
adapt
immun
respons
virushost
interact
determin
viru
virul
portal
entri
respiratori
virus
influenza
caus
sever
diseas
replic
well
lower
respiratori
tract
temperatur
close
howev
rhinovirus
grow
well
infect
lung
proper
confin
upper
respiratori
tract
sinc
adapt
replic
caus
mild
ill
common
cold
mention
coldadapt
influenza
viru
suffici
attenu
use
vaccin
instanc
attenu
associ
abil
replic
well
viremia
system
virus
spread
via
bloodstream
viral
strain
differ
durat
titer
induc
viremia
may
alter
abil
reach
critic
target
organ
therebi
influenc
virul
wildtyp
isol
polioviru
vari
degre
viremia
produc
correl
paralytogen
extraneur
infect
neural
spread
virus
spread
along
neural
pathway
rather
viremia
neural
spread
virus
also
experiment
attenu
rabi
viru
good
exampl
obligatori
neurotrop
attenu
vaccin
strain
rabi
viru
obtain
passag
wildtyp
viru
nonneur
cell
show
mark
reduct
virul
test
intracerebr
inject
mice
attenu
phenotyp
maintain
viru
passag
cell
come
kidney
tissu
revert
greater
virul
viru
passag
cultur
neural
cell
usual
astrocyt
brain
suckl
mice
neuroinvas
west
nile
viru
isol
group
two
major
lineag
base
upon
genet
sequenc
test
mice
isol
high
neurovirul
major
variat
neuroinvas
tabl
west
nile
viru
introduc
unit
state
see
chapter
emerg
viral
diseas
spread
new
york
state
across
countri
west
coast
outbreak
enceph
human
recent
isol
human
bird
unit
state
among
neuroinvas
strain
west
nile
viru
consist
sever
still
emerg
viral
diseas
variant
singl
viru
differ
rel
pathogen
differ
tissu
organ
confer
multidimension
charact
upon
virul
mention
search
attenu
polioviru
strain
sabin
use
passag
cell
cultur
obtain
viru
strain
use
formul
opv
fed
suscept
subject
strain
replic
well
wildtyp
isol
compar
wildtyp
isol
minim
neurovirul
monkey
anoth
exampl
strain
replic
well
primari
cultur
peripher
blood
mononuclear
cell
consist
mainli
lymphocyt
wildtyp
strain
also
replic
primari
cultur
monocytederiv
macrophag
transform
line
lymphocyt
explan
differ
tropism
macrophagetrop
strain
use
primari
receptor
effici
abil
requir
infect
macrophag
express
much
lower
level
lymphocyt
primari
isol
use
coreceptor
therefor
infect
cell
line
express
coreceptor
howev
primari
cultur
lymphocyt
express
high
level
coreceptor
use
strain
anim
host
evolv
larg
set
constitut
nonimmun
defens
viral
invad
mani
discov
recent
turn
virus
evolv
counter
measur
overcom
host
defens
counter
measur
one
determin
virul
best
studi
exampl
comparison
enzoot
siv
virus
african
nonhuman
primat
identifi
number
host
cellular
antivir
gene
protein
tetherin
constitut
host
intrins
defens
instanc
cognat
viral
protein
counteract
intrins
host
defens
see
chapter
hiv
aid
chapter
emerg
viral
diseas
exampl
sivcpz
chimpanze
acquir
african
monkey
underw
key
genet
chang
circumv
intrins
antivir
protein
encod
chimpanze
genom
turn
mutat
permit
sivcpz
cross
speci
barrier
human
share
similar
antivir
protein
chimpanze
pattern
dynam
innat
respons
specif
viru
strain
play
import
role
virul
varieti
studi
done
use
omic
approach
understand
innat
respons
viru
infect
virul
avirul
strain
influenza
viru
compar
mice
virul
viru
initi
faster
robust
sustain
inflammatori
respons
lung
figur
result
sever
lesion
korth
et
al
specul
similar
phenomenon
account
virul
influenza
viru
human
anoth
studi
found
dynam
inflammatori
respons
virus
mice
play
key
role
outcom
infect
rapid
respons
quickli
resolv
associ
surviv
recoveri
infect
resolv
quickli
respons
may
caus
much
inflamm
enhanc
pulmonari
dysfunct
endang
host
fatal
ebola
infect
associ
excess
outpour
proinflammatori
cytokin
cytokin
storm
dissemin
intravascular
coagulopathi
mcelroy
et
al
termin
event
appear
shock
syndrom
accompani
multipl
organ
failur
construct
mous
model
ebola
diseas
necessari
use
mouseadapt
strain
viru
rasmussen
et
al
screen
inbr
line
mice
show
select
line
suscept
fullblown
lethal
hemorrhag
shock
syndrom
line
could
infect
recov
lethal
outcom
associ
inflammatori
signal
vascular
permeabl
marker
cytokin
storm
mous
model
differ
host
suscept
appear
associ
differ
allel
endotheli
tyrosin
kinas
tek
gene
influenc
likelihood
cytokin
storm
remain
clarifi
alter
virul
pathogen
variant
virus
may
mediat
host
adapt
immun
respons
see
chapter
adapt
immun
instanc
clone
lymphocyt
choriomening
viru
lcmv
differ
armstrong
strain
virtu
abil
replic
rapidli
dendrit
cell
macrophag
profession
antigenpres
cell
rapid
destruct
dendrit
cell
clone
interfer
antigen
present
therebi
suppress
immun
respons
turn
permit
viru
escap
clearanc
result
clone
initi
persist
infect
without
acut
ill
contrast
armstrong
strain
interfer
induct
adapt
immun
caus
benign
immun
infect
rapid
viru
clearanc
differ
map
two
amino
acid
surfac
protein
lcmv
exampl
illustr
delic
balanc
acut
persist
infect
caus
differ
variant
singl
viru
dna
virus
larg
genom
particularli
herpesvirus
poxvirus
encod
number
protein
counter
host
defens
virokin
viral
protein
mimic
host
cytokin
stimul
cell
prolifer
increas
number
viru
target
viroceptor
viral
protein
mimic
receptor
host
defens
cytokin
decoy
away
intend
cellular
receptor
exampl
vaccinia
viru
encod
complement
control
protein
block
complement
cascad
tumor
necrosi
factor
viroceptor
bind
host
defens
molecul
herp
simplex
viru
hsv
encod
two
glycoprogein
ge
gi
act
fc
receptor
receptor
bind
inactiv
antivir
antibodi
prototyp
viral
infect
acut
induc
hostdefens
respons
clear
viru
leav
host
longlast
virusspecif
immun
howev
mani
virus
capabl
persist
often
lifetim
host
order
persist
delic
balanc
must
achiev
one
hand
host
kill
destruct
effect
viru
hand
viru
abl
evad
multitud
immun
defens
act
elimin
happen
theme
section
mechan
persist
rang
along
spectrum
sidebar
one
extrem
virus
continu
replic
high
titer
long
period
time
extrem
virus
becom
latent
emerg
rare
interv
replic
short
period
time
end
spectrum
exampl
smolder
infect
share
characterist
replic
latenc
virus
employ
varieti
strategi
escap
immun
surveil
tend
specif
differ
style
persist
thu
immun
toler
often
character
high
titer
persist
infect
wherea
activ
immun
respons
seen
mani
latent
infect
select
exampl
style
persist
list
tabl
prelud
consider
persist
use
briefli
recapitul
mechan
immun
respons
control
elimin
acut
viru
infect
innat
respons
effector
lymphocyt
destroy
virusinfect
cell
produc
antivir
cytokin
recruit
mononuclear
cell
site
viral
replic
destruct
see
chapter
innat
immun
adapt
respons
antibodi
neutral
opson
free
infecti
virion
see
chapter
adapt
immun
instanc
antibodi
virusspecif
effector
lymphocyt
purg
virusinfect
cell
without
destroy
mechan
viru
must
evad
order
persist
persist
viru
replic
high
titer
must
avoid
catastroph
pathogen
effect
either
acut
cytocid
attack
target
cell
replenish
regularli
effect
mani
virus
replic
product
without
caus
cell
death
number
caus
persist
infect
instanc
initi
dynam
resembl
acut
infect
follow
viru
titer
decreas
somewhat
reach
set
point
may
maintain
indefinit
gradual
declin
exampl
pattern
hepat
b
viru
hbv
hiv
lcmv
mice
immun
toler
persist
infect
nonlyt
virus
viru
persist
high
level
escap
effect
immun
respons
would
control
infect
therefor
hightit
viru
persist
often
accompani
immun
toler
appar
absenc
virusspecif
adapt
immun
mechan
toler
induc
includ
delet
forbidden
clone
lymphocyt
thymu
exhaust
peripher
virusspecif
lymphocyt
presenc
excess
antigen
see
chapter
aberr
immun
toler
may
limit
specif
compon
effector
limb
immun
respons
instanc
hepat
b
persist
character
absenc
antibodi
hbsag
hbcag
lcmv
persist
character
absenc
cellular
immun
respons
virusspecif
antibodi
produc
virusspecif
exhaust
effector
lymphocyt
best
analyz
lcmv
model
persist
infect
mark
differ
properti
lcmvspecif
virusspecif
memori
cell
gener
acut
versu
persist
infect
acut
infect
induc
memori
cell
exhibit
cardin
properti
selfrenew
absenc
antigen
high
level
receptor
wherea
memori
cell
anim
persist
infect
express
low
level
two
interleukin
receptor
gradual
disappear
absenc
antigen
model
memori
cell
associ
persist
infect
fail
differenti
effector
cell
capabl
erad
persist
infect
evid
lcmv
model
role
immun
toler
maintain
viral
persist
provid
experiment
termin
persist
intraven
inject
virusspecif
cell
obtain
anim
undergo
acut
infect
similar
result
obtain
hbv
cytolyt
lymphocyt
ctl
specif
hb
epitop
clear
viru
hepatocyt
lytic
virus
unusu
high
titer
persist
produc
cytolyt
viru
primat
lentivirus
repres
import
except
main
target
cell
lentivirus
lymphocyt
often
undergo
lytic
infect
calcul
continu
destruct
cell
result
reduct
averag
halflif
cell
day
howev
earli
cours
infect
bone
marrow
abl
respond
abnorm
rate
destruct
increas
product
cell
rate
suffici
maintain
reason
concentr
circul
cell
permit
lytic
viru
persist
high
titer
extend
period
time
rel
absenc
clinic
ill
eventu
bone
marrow
unabl
compens
level
drop
lead
function
immunodefici
high
titer
replic
requir
viru
either
noncytocid
rapid
replac
target
cell
cellular
prolifer
immun
surveil
unabl
elimin
viru
due
toler
immun
complex
format
viral
mutat
mechan
l
latenc
usual
requir
viral
genom
persist
nonrepl
mode
either
integr
genom
host
cell
episom
although
intermitt
activ
replic
may
occur
immun
surveil
may
compet
elimin
replic
viru
latent
viral
genom
l
smolder
infect
involv
continu
product
infect
celltocel
transmiss
low
level
potenti
effect
immun
surveil
circumv
mechan
antigen
variat
infecti
immun
complex
intercellular
bridg
contrast
high
titer
persist
infect
lentivirus
induc
immun
respons
rather
toler
immun
respons
lentivirus
quit
effect
judg
abil
rapidli
contain
acut
phase
infect
result
reduct
peak
viremia
week
set
point
lower
month
set
point
reach
dynam
equilibrium
establish
viru
product
clearanc
plasma
halflif
individu
siv
virion
min
absenc
immun
min
infect
anim
establish
immun
respons
calcul
maintain
viru
titer
infecti
virion
per
ml
plasma
requir
product
new
infecti
virion
daili
instanc
high
titer
persist
maintain
extraordinari
rate
viru
product
exce
rate
potent
cellular
immun
respons
clear
virusinfect
cell
see
chapter
mathemat
approach
discuss
differenti
equat
use
model
viral
product
clearanc
latent
infect
produc
consider
number
human
herpesvirus
includ
hsv
varicellazost
viru
vzv
epsteinbarr
viru
ebv
cytomegaloviru
cmv
characterist
sequenc
event
follow
primari
infect
initi
viru
replic
permiss
cell
portal
entri
viru
lytic
destroy
permiss
target
cell
immun
induct
occur
viru
clear
appear
elimin
howev
viral
genom
persist
latent
form
latenc
occur
one
cell
typessuch
neuron
hsv
vzvthat
distinct
permiss
cell
type
support
product
lytic
infect
neuron
restrict
permiss
depend
upon
physiolog
state
condit
restrict
viru
undergo
earli
step
entri
uncoat
step
replic
block
instanc
doublestrand
dna
genom
integr
host
genom
exampl
genom
persist
nonintegr
episom
nucleu
cytoplasm
latenc
occur
cell
type
thatlik
neuronsdo
divid
need
replic
latent
genom
viral
genom
integr
host
genom
retrovirus
automat
replic
cell
cycl
episom
dna
also
replic
enzym
involv
copi
cellular
genom
howev
parallel
mechan
rna
rna
virus
assum
latent
state
unless
undergo
revers
transcript
dna
intermedi
latenc
maintain
viral
genom
lifetim
infect
host
activ
latent
infect
may
occur
irregular
interv
may
never
occur
infect
individu
activ
latent
genom
initi
number
stimuli
characterist
viru
instanc
hsv
activ
fever
sunburn
trigemin
nerv
injuri
stimuli
appear
act
upon
primari
sensori
neuron
latent
hsv
genom
maintain
wane
immun
respons
enhanc
risk
activ
herpesvirus
vzv
follow
reactiv
hsv
viral
genom
may
spread
axoplasm
transport
centripet
centrifug
direct
centrifug
spread
conduct
viru
skin
may
replic
spread
caus
herp
labiali
fever
blister
cold
sore
spread
day
host
defens
prevent
spread
skin
lesion
heal
centripet
spread
trigemin
ganglion
conduct
hsv
genom
cn
rel
instanc
caus
devast
enceph
host
typic
virus
caus
latent
infect
induc
innat
acquir
immun
respons
brisk
potent
immun
respons
clear
initi
infect
latent
infect
activ
immun
surveil
limit
spread
viru
produc
activ
may
spread
anoth
host
instanc
activ
latent
vzv
produc
characterist
skin
lesion
older
adult
seroneg
children
expos
viru
aerosol
lesion
develop
chicken
pox
primari
form
vzv
infect
smolder
infect
fall
extrem
high
titer
persist
latenc
infecti
viru
produc
minim
level
may
requir
special
method
detect
isol
viru
continu
spread
infect
uninfect
cell
often
indol
tempo
viru
pathogen
may
produc
gradual
progress
chronic
diseas
detect
immun
respons
viru
abil
viru
spread
presenc
potenti
effect
immun
respons
paradox
phenomenon
involv
varieti
strategi
sever
describ
immunolog
privileg
site
organ
tissu
appear
favor
viru
persist
particularli
brain
kidney
brain
classic
consid
immunolog
privileg
site
immunolog
effector
mechan
may
spare
foreign
cell
brain
contrast
foreign
cell
site
least
two
factor
account
viru
persist
brain
first
bloodbrain
barrier
limit
traffick
lymphocyt
brain
second
neuron
express
littl
mhc
class
molecul
render
rel
poor
target
virusspecif
ctl
kidney
major
tissu
frequent
harbor
persist
virus
jc
bk
polyomavirus
cytomegaloviru
clear
explan
viru
kidney
abl
evad
immunolog
surveil
although
specul
lymphocyt
may
readili
cross
subendotheli
basement
membran
access
infect
glomerular
epitheli
cell
infecti
immun
complex
instanc
viru
persist
presenc
activ
immun
respons
infect
blood
circul
form
immun
complex
compos
infecti
virion
coat
virusspecif
antibodi
immun
complex
demonstr
addit
antiigg
antisera
neutral
infect
molecular
mechan
antibodyco
virion
retain
infect
never
well
elucid
one
possibl
complex
bound
fc
receptor
macrophag
intern
vacuol
complex
dissoci
follow
infect
macrophag
cours
persist
infect
may
select
viral
variant
abl
escap
neutral
resist
viru
variant
usual
repres
point
mutat
often
viral
attach
protein
phenomenon
observ
sever
persist
lentivirus
visnamaedi
viru
sheep
equin
infecti
anemia
viru
promin
hiv
discuss
chapter
hiv
aid
intercellular
bridg
instanc
process
entri
virus
cell
short
circuit
transient
intercellular
bridg
form
bridg
permit
viral
genom
pass
cell
cell
without
surviv
extracellular
environ
thu
provid
mean
avoid
neutral
antibodi
phenomenon
probabl
oper
subacut
scleros
panenceph
sspe
progress
fatal
neurolog
diseas
discuss
detail
sspe
defect
variant
measl
rubella
viru
spread
gradual
neuron
neuron
spite
extraordinarili
high
titer
neutral
antibodi
extracellular
fluid
brain
parenchyma
typic
cours
measl
spread
primarili
children
respiratori
rout
caus
system
febril
infect
rash
usual
resolv
week
seriou
consequ
howev
indic
previous
sspe
rare
complic
measl
case
per
primari
infect
occur
unpredict
appar
normal
children
follow
unev
recoveri
acut
measl
sever
year
measl
children
develop
progress
enceph
invari
fatal
month
measl
antigen
detect
either
biopsi
postmortem
brain
electron
microscopi
reveal
measl
nucleocapsid
neuron
glial
cell
brain
sspe
variant
virus
exhibit
underexpress
defect
one
viral
protein
mutat
inhibit
bud
product
freeinfecti
virion
exampl
escap
immun
surveil
associ
select
variant
virus
lose
abil
matur
bud
properli
maintain
gene
function
replic
viral
nucleocapsid
incomplet
viru
core
still
transmit
cell
cell
slowli
cytocid
lead
clinic
progress
ultim
fatal
enceph
hbv
infect
follow
differ
cours
depend
upon
age
time
infect
infect
adult
often
selflimit
acut
process
clearanc
viru
usual
accompani
hepat
neonat
infect
transmiss
woman
chronic
viru
carrier
newborn
infant
usual
lead
persist
figur
infect
infant
high
level
circul
hbsag
serum
hbv
dna
antihb
viral
surfac
antigen
antihb
precor
antigen
antibodi
detect
serum
infect
infant
antihbc
viral
core
antigen
antibodi
present
state
sometim
call
split
toler
persist
associ
high
dose
cellular
toler
hbsag
minim
level
hbsspecif
cell
due
delet
exhaust
antigenspecif
lymphocyt
sinc
cell
play
major
role
control
clearanc
hbv
major
factor
persist
persist
hbv
high
titer
replic
may
last
decad
lifetim
howev
unknown
mechan
infect
may
shift
one
three
mode
low
replic
phase
immunoact
phase
high
replic
phase
low
replic
phase
patient
may
control
clear
infect
develop
antihb
antibodi
recoveri
cellular
immun
immunoact
high
replic
phase
immun
respons
attempt
clear
viru
partial
success
result
necroinflammatori
hepat
may
progress
cirrhosi
perman
liver
damag
andor
hepatocellular
carcinoma
viru
virul
host
suscept
interdepend
properti
determin
virushost
combin
togeth
result
manifest
infect
viru
virul
one
set
may
innocu
anoth
host
may
suscept
resist
depend
upon
age
rout
infect
properti
viru
viru
virul
measur
varieti
way
base
mortal
ill
patholog
lesion
quantifi
virul
phenotyp
also
may
qualit
involv
differ
tropism
differ
viral
variant
wildtyp
isol
viru
may
vari
virul
virul
variant
also
select
experiment
manipul
attenu
variant
often
exhibit
host
rang
temperaturesensit
phenotyp
may
provid
candid
live
viru
vaccin
attenu
phenotyp
manifest
step
cours
infect
invas
spread
involv
target
organ
shed
virul
attenu
map
specif
viral
gene
individu
nucleotid
may
associ
one
mani
viral
gene
includ
noncod
sequenc
virus
larg
complex
genom
virul
may
confer
accessori
gene
act
virokin
viroceptor
number
virus
wide
varieti
viru
famili
persist
month
year
even
lifelong
persist
infect
delic
balanc
host
kill
destruct
effect
viru
viru
manag
evad
immun
surveil
persist
infect
fall
one
three
distinct
pattern
persist
virususu
noncytocid
agentat
high
titer
variou
tissu
often
associ
immun
toler
due
delet
exhaust
antigenspecif
lymphocyt
latent
infect
viru
persist
untransl
genom
elud
recognit
host
immun
respons
latent
infect
may
reactiv
period
reactiv
usual
termin
host
immun
surveil
smolder
infect
fall
two
pattern
viru
continu
replic
low
level
face
brisk
immun
respons
evas
immun
surveil
achiev
number
mechan
immunolog
privileg
tissu
site
intercellular
bridg
antigen
variat
persist
infect
may
asymptomat
often
associ
wide
varieti
chronic
diseas
see
follow
chapter
persist
viral
infect
also
lead
cancer
hbv
infect
begin
immunotoler
process
high
viru
titer
minim
cellular
immun
respons
may
last
decad
lifetim
howev
reason
known
infect
may
shift
one
three
mode
low
replic
phase
immunoact
phase
high
replic
phase
low
replic
phase
patient
may
control
clear
infect
develop
antihb
antibodi
recoveri
cellular
immun
immunoact
high
replic
phase
immun
respons
attempt
clear
viru
partial
success
result
necroinflammatori
hepat
may
progress
cirrhosi
perman
liver
damag
alt
alanin
transaminas
liver
enzym
whose
level
serum
reflect
liver
function
rehermann
b
nascimbeni
immunolog
hepat
b
viru
hepat
c
viru
infect
natur
review
immunolog
permiss
